Home » Topics » Regulatory » Patents

Patents
RSS

Selective dopamine D3 receptor ligands developed at Neurogen

May 22, 1998

Cytokine-suppressive antiinflammatory drugs from SKB

May 22, 1998

New penems in development at Menarini and Lusofarmaco

May 21, 1998

Phosphonate nucleotides with antiviral/antitumor activity from Mitsubishi

May 21, 1998

Research at Kowa leads to potent inhibitors of IgE antibody production

May 21, 1998

Heterocyclic cholesterol biosynthesis inhibitors discovered at Zeneca

May 21, 1998

Merck KGaA synthesizes new series of PDE IV inhibitors

May 21, 1998

Boehringer Ingelheim prepares novel immunomodulators

May 21, 1998

DuPont Merck presents new anticoagulants

May 21, 1998

Celgene claims agents for reducing cytokine levels

May 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...